本页面由Tiger Trade Technology Pte. Ltd.提供服务

拜玛林制药

55.39
+0.59501.09%
盘后:55.630.2400+0.43%19:55 EDT
成交量:236.52万
成交额:1.31亿
市值:107.05亿
市盈率:146.15
高:55.96
开:55.56
低:54.90
收:54.80
52周最高:70.98
52周最低:49.26
股本:1.93亿
流通股本:1.92亿
量比:0.88
换手率:1.23%
股息:- -
股息率:- -
每股收益(TTM):0.3790
每股收益(LYR):1.80
净资产收益率:1.18%
总资产收益率:3.26%
市净率:1.69
市盈率(LYR):30.77

数据加载中...

2024/04/26

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/24

重要事件披露

Form 8-K - Current report
2024/04/23

重要事件披露

Form 8-K - Current report
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities